'Slight mutations, minor variants of Covid not to impact efficacy of current vaccines' : vimarsana.com

'Slight mutations, minor variants of Covid not to impact efficacy of current vaccines'


‘Slight mutations, minor variants of Covid not to impact efficacy of current vaccines’
June 13, 2021
Aparna Mukherjee, Senior Scientist, Indian Council of Medical Research×
ICMR scientist also warns of possibility of third wave as lockdown is being lifted
The currently used vaccines – Covaxin, Covishield and Sputnik V vaccines – deployed by India in its fight against Covid-19 are able to generate antibodies against the Coronavirus and neutralise it and a slight mutation or the minor variants of the virus may not affect the efficacy of these vaccines, Aparna Mukherjee, Senior Scientist at the Indian Council of Medical Research, has said.
Speaking to

Related Keywords

India , Bharat , Aparna Mukherjee , Monika Yadav , Indian Council Of Medical Research , Senior Scientist , Indian Council , Medical Research , Bharat Biotech , Drug Controller General , Rapid Antigen Tests , Covid 19 , Covaxin , Covishield And Sputnik V , Vaccines , Icmr Mutations , Pandemic , Rtpcr , Test , Infection , Remdesivir , Ivermectin , இந்தியா , பாரத் , அபர்னா முகர்ஜி , மோனிகா யாதவ் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மூத்தவர் விஞ்ஞானி , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , பாரத் பயோடெக் , மருந்து கட்டுப்படுத்தி ஜநரல் , தடுப்பு மருந்துகள் , சர்வதேச பரவல் , சோதனை , தொற்று ,

© 2024 Vimarsana